These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 24288553)
1. Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma. Wang N; Luo HJ; Yin GB; Dong CR; Xu M; Chen GG; Liu ZM Clin Dev Immunol; 2013; 2013():589423. PubMed ID: 24288553 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma. Wang N; Dong CR; Jiang R; Tang C; Yang L; Jiang QF; Chen GG; Liu ZM Int J Clin Exp Pathol; 2014; 7(1):322-30. PubMed ID: 24427353 [TBL] [Abstract][Full Text] [Related]
3. Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma. Liu YM; Ying SP; Huang YR; Pan Y; Chen WJ; Ni LQ; Xu JY; Shen QY; Liang Y World J Surg Oncol; 2016 Feb; 14(1):30. PubMed ID: 26846782 [TBL] [Abstract][Full Text] [Related]
4. High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma. Tang C; Yang L; Wang N; Li L; Xu M; Chen GG; Liu ZM Int J Clin Exp Pathol; 2014; 7(6):3213-23. PubMed ID: 25031742 [TBL] [Abstract][Full Text] [Related]
5. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma. Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590 [TBL] [Abstract][Full Text] [Related]
6. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma. Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160 [TBL] [Abstract][Full Text] [Related]
7. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma]. Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314 [TBL] [Abstract][Full Text] [Related]
8. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma. Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma. Wu G; Zhou Y; Li T; Guo J; Zhou Z J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894 [TBL] [Abstract][Full Text] [Related]
10. CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis. Yasuoka H; Kodama R; Hirokawa M; Takamura Y; Miyauchi A; Sanke T; Nakamura Y BMC Cancer; 2008 Sep; 8():274. PubMed ID: 18826577 [TBL] [Abstract][Full Text] [Related]
11. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features]. Jiang XL; Zhang H; Chen YL; Peng L Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755 [No Abstract] [Full Text] [Related]
12. The association of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α protein expression with clinicopathological characteristics in papillary thyroid carcinoma: A meta-analysis. Lin X; Su H; Huo J; Zhang F Medicine (Baltimore); 2023 Jun; 102(24):e34045. PubMed ID: 37327294 [TBL] [Abstract][Full Text] [Related]
13. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma. Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160 [TBL] [Abstract][Full Text] [Related]
14. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma. Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325 [TBL] [Abstract][Full Text] [Related]
16. Differential protein expression of lymph node metastases of papillary thyroid carcinoma harboring the BRAF mutation. Park WS; Chung KW; Young MS; Kim SK; Lee YJ; Lee EK Anticancer Res; 2013 Oct; 33(10):4357-64. PubMed ID: 24123003 [TBL] [Abstract][Full Text] [Related]
17. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma]. Yue C; Zhao X; Tian C; Jin Y; Liu H Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):490-4. PubMed ID: 26705040 [TBL] [Abstract][Full Text] [Related]
18. A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinoma. Lee J; Seol MY; Jeong S; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS Medicine (Baltimore); 2015 Jan; 94(2):e380. PubMed ID: 25590838 [TBL] [Abstract][Full Text] [Related]
19. mRNA expression pattern of retinoic acid and retinoid X nuclear receptor subtypes in human thyroid papillary carcinoma. Macejová D; Galbavý S; Podoba J; Bialešová L; Brtko J Oncol Rep; 2013 Nov; 30(5):2371-8. PubMed ID: 23969901 [TBL] [Abstract][Full Text] [Related]
20. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma. Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]